rss
Ann Rheum Dis 2001;60:278-280 doi:10.1136/ard.60.3.278
  • Concise report

Evaluation of hand function in patients undergoing long term haemodialysis

  1. V Limaye,
  2. A Frankham,
  3. A Disney,
  4. K Pile
  1. Queen Elizabeth Hospital, Woodville, Adelaide, Australia
  1. Dr K Pile, Rheumatology Department, Queen Elizabeth Hospital, University of Adelaide, 28 Woodville Road, Woodville South, SA 5011, Australia kevin.pile{at}adelaide.edu.au
  • Accepted 6 July 2000

Abstract

OBJECTIVE Haemodialysis is associated with the deposition of β2 microglobulin in musculoskeletal structures, leading to the syndrome of dialysis related amyloidosis and impairment of hand function. This study aimed at assessing hand function using the Sollerman test in a cross section of patients undergoing haemodialysis.

METHODS Recipients of haemodialysis underwent the Sollerman test of hand grip function, which assesses 20 activities of daily living using eight grip types, and the JAMAR grip strength test, visual analogue scales (VAS) for pain (VAS-P) and function (VAS-F), and Health Assessment Questionnaire (HAQ) were determined. Results—Thirty five subjects (26 male), with mean age 53.2 years, participated. The average duration of haemodialysis was 6.2 years (range one month to 25 years). The median Sollerman score was 77, with 19/35 (54%) patients receiving haemodialysis having a score below the lower normal value of 78–80. The log Sollerman score correlated poorly with age (r s=0.16, p=0.35), and significantly with the HAQ score (r s=−0.66, p<0.00005), duration of haemodialysis (r s=−0.39, p<0.05), VAS-F (r s=−0.41, p<0.05), VAS-P (r s=−0.34, p<0.05), and JAMAR score (r s=0.57, p<0.05). Sollerman scores were highly correlated between dominant and non-dominant hands (r s=0.69, p<000005).

CONCLUSIONS Hand dysfunction is a common finding among patients undergoing long term haemodialysis. The Sollerman test accurately reflects patient function as measured by HAQ, VAS-F, and grip strength, but less so pain. Its use for the early detection of dialysis related amyloidosis and in the serial monitoring of the effects of hand treatment programmes is encouraged.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.